Historical salary details - Ms. Bernadette M. Connaughton, Independent Director, Halozyme Therapeutics Inc.
Ms. Bernadette M. Connaughton is the Independent Director of Halozyme Therapeutics Inc.. They also hold 1 other positions in and Editas Medicine Inc.
Ms. Bernadette M. Connaughton
Independent Director
$ 617.9 K
Gross Remuneration
-
Current Company
Halozyme Therapeutics Inc.
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Halozyme Therapeutics Inc. | Independent Director | 470.0 K | - |
| 2024 | Editas Medicine Inc | Independent Director | 147.8 K | -31.3 % |
| 2023 | Editas Medicine Inc | Independent Director | 215.1 K | -16.4 % |
| 2023 | Halozyme Therapeutics Inc. | Independent Director | - | - |
| 2022 | Halozyme Therapeutics Inc. | Independent Director | 320.0 K | -0.0 % |
| 2022 | Editas Medicine Inc | Independent Director | 257.1 K | -57.8 % |
| 2021 | Editas Medicine Inc | Independent Director | 608.8 K | - |
| 2021 | Halozyme Therapeutics Inc. | Independent Director | 320.0 K | 18.0 % |
| 2020 | Halozyme Therapeutics Inc. | Independent Director | 271.3 K | 1.7 % |
| 2019 | Halozyme Therapeutics Inc. | Independent Director | 266.6 K | 130.3 % |
| 2018 | Halozyme Therapeutics Inc. | Independent Director | 115.8 K | - |